How to evaluate an Analytics and Decision Sciences Partner

whitePaper | February 24, 2022

Today’s business relies on access to critical data more than ever to remain ahead of the competition. Due to the challenges over the last two years, organizations must respond to greater demand for data access and a shift to supporting AI/ML in a complex, hybrid multi-cloud environment. Organizations need to become nimble in providing fast, reliable access to data anytime, anywhere, throughout their increasingly complex, integrated enterprise.

whitePaper | January 11, 2023

The world of master data management (MDM) is a complicated place to navigate and its native speakers use a language sometimes only they themselves understand. It is packed with complex descriptions, esoteric lingo and acronyms.

whitePaper | August 1, 2022

The Graph database is fundamental to driving a much-needed breakthrough in the world of Master Data Management (MDM). Until now, traditional MDM systems have imposed strict rules and structures on how these projects are managed. This has cost enterprises dearly in terms of wasted time and resources and has been a major contributory factor to the failure of many MDM initiatives. Graph has changed all of that, allowing modern MDM platforms to completely redefine how master data is prepared for insight and used to deliver tangible business outcomes.

whitePaper | September 26, 2022

Communications service provider (SP) traffic volumes are progressively increasing as networks evolve, user devices gain greater capacity, and applications engaging with advanced network data such as that from the 5G standalone (5G SA) network exposure function (NEF) start to deliver on customer expectations. Cloudification of network functions — virtualized network functions (VNFs) and cloud-native network functions (CNFs) — is placing new burdens on old systems and processes not designed to manage intent-based network architecture. Silos of data locked within many installed systems keep transformation efforts from reaching anticipated objectives.

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.

whitePaper | December 12, 2022

In August 2022, the California Office of the Attorney General announced a $1.2 million settlement with international cosmetic retailer Sephora for violations of the California Consumer Privacy Act. Following this announcement came a wave of questions about the regulator’s emphasis on the broad interpretation of the CCPA’s “sale of data” and adoption of the Global Privacy Control.